Cargando…
BRAF Inhibitors in Metastatic Colorectal Cancer and Mechanisms of Resistance: A Review of the Literature
SIMPLE SUMMARY: The MAP kinases pathway has shown a key role in the pathogenesis of colorectal cancer. The development of targeted therapy against BRAF-mutated tumors is changing the management of advanced disease. A proper understanding of the mechanisms of acquired resistance is essential to optim...
Autores principales: | Guerrero, Patricia, Albarrán, Víctor, San Román, María, González-Merino, Carlos, García de Quevedo, Coral, Moreno, Jaime, Calvo, Juan Carlos, González, Guillermo, Orejana, Inmaculada, Chamorro, Jesús, Martínez-Delfrade, Íñigo, Morón, Blanca, de Frutos, Belén, Ferreiro, María Reyes |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10649848/ https://www.ncbi.nlm.nih.gov/pubmed/37958416 http://dx.doi.org/10.3390/cancers15215243 |
Ejemplares similares
-
Current Landscape and Potential Challenges of Immune Checkpoint Inhibitors in Microsatellite Stable Metastatic Colorectal Carcinoma
por: San-Román-Gil, María, et al.
Publicado: (2023) -
Localized Colonic Small-Cell Carcinoma with Pathological Complete Response after Neoadjuvant Cisplatin and Etoposide: A Case Report
por: Alía Navarro, Víctor, et al.
Publicado: (2023) -
Her-2 Targeted Therapy in Advanced Urothelial Cancer: From Monoclonal Antibodies to Antibody-Drug Conjugates
por: Albarrán, Víctor, et al.
Publicado: (2022) -
Current Landscape of Immunotherapy for Advanced Sarcoma
por: Albarrán, Víctor, et al.
Publicado: (2023) -
Receptor Tyrosine Kinase Inhibitors for the Treatment of Recurrent and Unresectable Bone Sarcomas
por: Albarrán, Víctor, et al.
Publicado: (2022)